Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Outcomes Of The Spanish Cohort Of Early Access To Pertuzumab And Trastuzumab Emtansine (KNOWHER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03025711
Recruitment Status : Recruiting
First Posted : January 19, 2017
Last Update Posted : January 31, 2019
Information provided by (Responsible Party):
BELEN RUIZ-ANTORAN, Puerta de Hierro University Hospital

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Actual Primary Completion Date : October 1, 2018
Estimated Study Completion Date : July 31, 2019